The ECM remodeling is one of the prominent pathologies of glaucoma and we previously reported that statins inhibit ECM protein expressions and matrix metalloproteinases in ONH astrocytes in response to TGF-β2 [11,25]. The gene discussed is TGFB2; the disease is glaucoma.